Purpose: The aim of this study was to develop and evaluate application software for physicians to explain medication efficacy to patients with epilepsy. Methods: We developed application software for visualization of the attenuation of epileptic seizures on a three-dimensional (3-D) brain-surface shape model using magnitude texture mapping of abnormal neural activity. The magnitude of the abnormal neural activity was mathematically simulated by the Kim-Robinson model. The efficacy of the developed application software was confirmed by neurosurgeons (n = 7) via questionnaire. Results: The developed software was useful in explaining brain anatomy and function, epileptic seizure and medication adherence. Conclusions: The virtual reality application software developed in this study can be used to support patient awareness of the pathophysiology of epileptic seizures.
Methods

1 Requirement specifications
The application software was designed as a support tool to be used by physicians when giving medication instructions to patients. The requirement specifications were as follows:
i. The seizures were visualized on a 3D brain-surface shape model (BSM) in a virtual reality space to help patients intuitively understand anatomical information.
ii. The target epileptic seizures were focal seizures that occurred on the cerebral surface of the brain; temporal changes in the seizures were visualized on the BSM.
iii. Seizure suppression via antiepileptic drugs was visualized.
2 Equipment and materials
1 BSM generation
Manual segmentation of brain magnetic resonance (MR) Figure 1 . The brain-surface shape model (BSM) generated from magnetic resonance (MR) images and S is an external stimulus. F, C and S are defined in the following equations:
where, c 1 , c 2 , c 3 , ε 2 , ε 3 are the parameter constants, t 0 is the loop delay, γ e is the length of the axon between the cortices, t 1 is the start time of the external stimulus, and ψ 0 is the initial potential of the external stimulus.
Since can be approximated by white noise 9) , we used white gauss noise (σ= 0.0003). Table 1 shows the parameter values in this study. with NP values for each pixel was converted to a color (RGB) image (Fig. 3) and mapped to the BSM along the UV coordinate. In this study, red was used for the high absolute NP value, yellow represented the middle value, and green indicated a low value.
3 Visualization of seizure suppression via antiepileptic drugs
To promote intuitive understanding of drug effects and to explain the importance of medication adherence, suppression of seizures was visualized. In KRM, the oscillation of NP activity depends on the parameter c 1
7, 9)
. So, we simulated suppression by changing c 1
4 Implementation of the application software
The visualization software was developed for Windows (2) and suppressed the seizure when the slider was raised.
3 Evaluation experiment
The subjects were 7 neurosurgeons. The sampling method was opportunistic and an anonymous self-report study was conducted. Two questionnaires (pre-and postsurvey) were administered. A visual analog scale was employed for evaluation.
The pre-survey questionnaire included the following: The questionnaire for the post-survey was made based on ISO/IEC 25000 international standards: Software Product Quality Requirements and Evaluation (SQuaRE) 10, 11) .
The post-survey questionnaire was a functionality assessment (FA) to measure whether the application matched its purpose, and a usability evaluation (UE) related to application operation. In this study, the FA examined the advantages of using the 3D application compared with conventional methods which were the choses in re-survey questionnaire.
The FA included the following possible answers: (1) it will be easier to explain brain anatomy and function;
(2) it will be easier to explain the propagation of epileptic seizures; (3) it will be easier to give medication instructions; (4) it will help share visual information between doctors and patients; (5) Tables 2-4 show the results of the pre-survey questionnaire. Two out of seven participants were epileptic specialists. All subjects had faced difficulty when explaining epilepsy, and 6 subjects had given an oral explanation only. It was especially difficult to explain brain anatomy, brain function, and medication. Some subjects reported that the reason for difficulty with "the things related to medication" was that it is difficult to explain the mechanism and necessity of antiepileptic drug treatment. Table 5 shows the results of the post-survey FA questionnaire. The answer "It will be easier to explain brain anatomy and function" had the highest score: Table 2 . Results of the pre-survey questionnaire (yes/no questions) (n = 7) Table 3 . Results of the pre-survey questionnaire (multiple choice question) (n = 7) Table 4 . Results of the pre-survey questionnaire (multiple choice question) (n = 7) Table 5 . Post-survey questionnaire/functionality (visual analog scale [VAS]) (n = 7) Table 6 . Post-survey questionnaire/usability (VAS) (n = 7)
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Discussion
We developed application software to help patients intuitively understand the pathophysiology of epilepsy and to help physicians explain the importance of medication adherence to their patients. The main advantage of our system is that it allows 3D visualization of the brain and temporal abnormal neural activity at the onset of epileptic seizures. Further, it simulates the suppression of seizures when the antiepileptic drug dose is increased.
The lack of patient understanding of the disease and treatment regimen may affect compliance with drug treatment. In this study, the results of the pre-survey questionnaire showed that most physicians only gave oral explanations to patients with epilepsy, and that physicians felt it was difficult to explain the importance of medical adherence. In Japan, physicians did not have enough time to explain medical adherence but thought the patients understood their oral explanations. In fact, some physicians reported that most patients understood the content of their explanations to some extent.
In the FA questionnaire, the brain anatomy and function question score was high and the SD was small. The propagation of epileptic seizures and medication question scores were also high. This suggests that our software was useful in explaining brain anatomy and function, epileptic seizures, and medication adherence.
The propagation of epileptic seizures and medication question scores were lower than the brain anatomy and function question score. The reason may be that the epileptic seizure simulation algorithm only applied to the brain surface. Therefore, physicians who wanted to use it for other seizure types (e.g., those due to hippocampal sclerosis) might have given the application a low score. Additionally, the seizure suppression simulation algorithm only allowed for visualization of the effect and did not describe the drug mechanism. Therefore, physicians who wanted to explain the drug mechanism during consultation might have given a lower score. We will attempt to refine these points in the next study.
The application received high UE scores for ease of understanding and operation. Reason for this result might be that it can be operated using a mouse only and that the GUI is easy to navigate.
A limitation of this study is that it was difficult to validate the seizure simulation using actual epileptic seizure phenomena. This is because scalp electroencephalograms (EEGs) are not always accurate and intracranial EEGs can only measure a limited area. Additionally, we did not evaluate the subjects' perception of the software instructions.
Conclusion
We developed application software to help physician explain epileptic seizures to patients. It simulated and allowed visualization of epileptic seizures on the brain surface using the KRM and UV mapping. The results of the evaluation experiment indicated that it might be easier to explain brain anatomy and function using the application compared with using conventional explanations. We will evaluate the application from patient side in next study.
